Biohaven Ltd.
BHVN
$9.20
$0.121.32%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -21.71% | -7.43% | 37.22% | 44.22% | 24.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.13% | -44.34% | -4.93% | 30.78% | 20.91% |
| Operating Income | 41.13% | 44.34% | 4.93% | -30.78% | -20.91% |
| Income Before Tax | 41.08% | 22.27% | -8.02% | 38.08% | -23.55% |
| Income Tax Expenses | -55.34% | 631.25% | 474.58% | 47.46% | 7.03% |
| Earnings from Continuing Operations | 41.12% | 22.10% | -8.20% | 38.03% | -23.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 41.12% | 22.10% | -8.20% | 38.03% | -23.49% |
| EBIT | 41.13% | 44.34% | 4.93% | -30.78% | -20.91% |
| EBITDA | 41.61% | 44.98% | 5.63% | -31.14% | -20.64% |
| EPS Basic | 59.33% | 34.50% | 3.50% | 46.88% | 1.15% |
| Normalized Basic EPS | 59.07% | 51.66% | 5.10% | -13.36% | 1.59% |
| EPS Diluted | 59.33% | 34.50% | 3.50% | 46.88% | 1.15% |
| Normalized Diluted EPS | 59.07% | 51.66% | 5.10% | -13.36% | 1.59% |
| Average Basic Shares Outstanding | 44.80% | 18.93% | 12.13% | 16.64% | 24.93% |
| Average Diluted Shares Outstanding | 44.80% | 18.93% | 12.13% | 16.64% | 24.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |